Literature DB >> 30208377

The Latent Structure of Negative Symptoms in Schizophrenia.

Gregory P Strauss1, Alicia Nuñez2, Anthony O Ahmed3, Kimberly A Barchard2, Eric Granholm4,5, Brian Kirkpatrick6, James M Gold7,8, Daniel N Allen2.   

Abstract

Importance: Negative symptoms are associated with a range of poor clinical outcomes, and currently available treatments generally do not produce a clinically meaningful response. Limited treatment progress may be owing in part to poor clarity regarding latent structure. Prior studies have inferred latent structure using exploratory factor analysis, which has led to the conclusion that there are 2 dimensions reflecting motivation and pleasure (MAP) and diminished expressivity (EXP) factors. However, whether these conclusions are statistically justified remains unclear because exploratory factor analysis does not test latent structure. Confirmatory factor analysis (CFA) is needed to test competing models regarding the latent structure of a construct. Objective: To evaluate the fit of 4 models of the latent structure of negative symptoms in schizophrenia using CFA. Design, Setting, and Participants: Three cross-sectional studies were conducted on outpatients with schizophrenia who were rated on the 3 most conceptually contemporary measures: Scale for the Assessment of Negative Symptoms (SANS), Brief Negative Symptom Scale (BNSS), and Clinical Assessment Interview for Negative Symptoms (CAINS). Confirmatory factor analysis evaluated the following 4 models: (1) a 1-factor model; (2) a 2-factor model with EXP and MAP factors; (3) a 5-factor model with separate factors for the 5 domains of the National Institute of Mental Health consensus development conference (blunted affect, alogia, anhedonia, avolition, and asociality); and (4) a hierarchical model with 2 second-order factors reflecting EXP and MAP and 5 first-order factors reflecting the 5 consensus domains. Main Outcomes and Measures: Outcomes included CFA model fit statistics derived from symptom severity scores on the SANS, BNSS, and CAINS.
Results: The study population included 860 outpatients with schizophrenia (68.0% male; mean [SD] age, 43.0 [11.4] years). Confirmatory factor analysis was conducted on each scale, including 268 patients for the SANS, 192 for the BNSS, and 400 for the CAINS. The 1- and 2-factor models provided poor fit for the SANS, BNSS, and CAINS as indicated by comparative fit indexes (CFIs) and Tucker Lewis indexes (TLIs) less than 0.950, RMSEAs that exceeded the 0.080 threshold, and WRMRs greater than 1.00. The 5-factor and hierarchical models provided excellent fit, with the 5-factor model being more parsimonious. The CFIs and TLIs met the 0.95 threshold and the 1.00 threshold for both factor models with all 3 measures. Interestingly, the RMSEAs for the 5-factor model and the hierarchical model fell under the 0.08 threshold for the BNSS and the CAINS but not the SANS. Conclusions and Relevance: These findings suggest that the recent trend toward conceptualizing the latent structure of negative symptoms as 2 distinct dimensions does not adequately capture the complexity of the construct. The latent structure of negative symptoms is best conceptualized in relation to the 5 consensus domains. Implications for identifying pathophysiological mechanisms and targeted treatments are discussed.

Entities:  

Mesh:

Year:  2018        PMID: 30208377      PMCID: PMC6583036          DOI: 10.1001/jamapsychiatry.2018.2475

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  36 in total

1.  The distinction of positive and negative symptoms. The failure of a two-dimensional model.

Authors:  S Arndt; R J Alliger; N C Andreasen
Journal:  Br J Psychiatry       Date:  1991-03       Impact factor: 9.319

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Meta-analysis of symptom factors in schizophrenia.

Authors:  B S Grube; R M Bilder; R S Goldman
Journal:  Schizophr Res       Date:  1998-05-25       Impact factor: 4.939

4.  The factorial structure of the schedule for the deficit syndrome in schizophrenia.

Authors:  David Kimhy; Scott Yale; Raymond R Goetz; Lynn Marcinko McFarr; Dolores Malaspina
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

Review 5.  Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update.

Authors:  N C Andreasen; S Arndt; D Miller; M Flaum; P Nopoulos
Journal:  Psychopathology       Date:  1995       Impact factor: 1.944

Review 6.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

7.  The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

Authors:  Robert W Buchanan; Daniel C Javitt; Stephen R Marder; Nina R Schooler; James M Gold; Robert P McMahon; Uriel Heresco-Levy; William T Carpenter
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

8.  The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Authors:  Ann M Kring; Raquel E Gur; Jack J Blanchard; William P Horan; Steven P Reise
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

Review 9.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

10.  Should researchers use single indicators, best indicators, or multiple indicators in structural equation models?

Authors:  Leslie A Hayduk; Levente Littvay
Journal:  BMC Med Res Methodol       Date:  2012-10-22       Impact factor: 4.615

View more
  33 in total

Review 1.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

2.  Toward a Complex Network of Risks for Psychosis: Combining Trauma, Cognitive Biases, Depression, and Psychotic-like Experiences on a Large Sample of Young Adults.

Authors:  Łukasz Gawęda; Renata Pionke; Jessica Hartmann; Barnaby Nelson; Andrzej Cechnicki; Dorota Frydecka
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 3.  Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains.

Authors:  Gregory P Strauss; Anthony O Ahmed; Jared W Young; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

4.  Digital phenotyping of negative symptoms: the relationship to clinician ratings.

Authors:  Alex S Cohen; Elana Schwartz; Thanh P Le; Tovah Cowan; Brian Kirkpatrick; Ian M Raugh; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

5.  The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.

Authors:  Wing Chung Chang; Gregory P Strauss; Anthony O Ahmed; Sandra C Y Wong; Joe K N Chan; Edwin H M Lee; Sherry K W Chan; Christy L M Hui; Sydney H James; Hannah C Chapman; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

6.  Mapping the Research Domain Criteria Social Processes Constructs to the Social Responsiveness Scale.

Authors:  Mirko Uljarević; Thomas W Frazier; Jennifer M Phillips; Booil Jo; Sandy Littlefield; Antonio Y Hardan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-01       Impact factor: 8.829

7.  Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome.

Authors:  Ian M Raugh; Sydney H James; Cristina M Gonzalez; Hannah C Chapman; Alex S Cohen; Brian Kirkpatrick; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

8.  A Meta-Analysis of Neuropsychological Effort Test Performance in Psychotic Disorders.

Authors:  Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Gregory P Strauss
Journal:  Neuropsychol Rev       Date:  2020-08-07       Impact factor: 7.444

9.  Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss; Farnaz Zamani Esfahlani; Silvana Galderisi; Armida Mucci; Alessandro Rossi; Paola Bucci; Paola Rocca; Mario Maj; Brian Kirkpatrick; Ivan Ruiz; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

10.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.